Over the period of the past 20 years, the prevalence of asthma and obesity in the United States have increased significantly. 1, 2 According to the latest National Health and Nutrition Examination Survey, more than 10 million (5.2%) US adults report having a current asthma diagnosis, 3 and approximately 30% of the US population meets the criteria for obesity on the basis of a body mass index (BMI) 30 kg/m 2 . 4 The prevalence of asthma and obesity has been most notable among ethnic minorities, a group disproportionably affected by both disorders. 5, 6 In addition, African Americans have been shown to have higher asthma-related morbidity, including hospital outpatient visits (14.2% vs 5.5%) and emergency department visits (21.0% vs 7.0%), compared with whites. 7 Epidemiologic studies looking at the relationship between obesity and asthma have found increasing BMI to be associated with increased asthma incidence. 8 Whether this association is coincidental or a result of a true physiologic link remains unclear. To date, studies looking at the association of obesity and cardinal features of asthma pathophysiology, such as hyperresponsiveness 9 and airflow limitation, 10, 11 have yielded conflicting results. Although weight loss has been shown to lead to improved symptoms in patients with asthma, studies have failed to shown any effect of weight loss on pathophysiologic features of asthma. 12 Obesity is associated with changes in lung volumes and gastroesophageal symptoms (ie, gastroesophageal reflux disease), which may mimic asthma and contribute to inaccurate diagnosis of asthma in the morbidly obese. 13 Furthermore, obesity and asthma may share common risk factors such as behavioral, environmental, and genetic factors that may account for their epidemiology link.
14 Given the lack of consistency regarding the association between obesity and asthma pathophysiology, it is also debatable whether previous reports of a positive association between obesity and worse asthma severity [15] [16] [17] are in part a result of publication bias, with failure of the literature to report negative studies.
Asthma control questionnaires have been used extensively in research to assess disease activity and/or evaluate treatment effectiveness. 18, 19 Moreover, clinical studies have shown inadequately controlled asthma, assessed using asthma control questionnaires, to be associated with worse asthma outcomes. 19, 20 According to the 2007 National Asthma Education and Prevention Program guidelines, asthma control assessed using patientreported validated asthma symptom questionnaires should be used rather than asthma severity in the long-term treatment of 21 Given that poor asthma control is associated with increased risk of hospitalization and acute health care use, 20, 22 we sought to determine whether obesity contributes to worse asthma control in a urban community-based sample of people with asthma and a high prevalence of obesity. We hypothesized that subjects with higher BMI would have worse asthma control.
METHODS
The data for this study were collected as part of a clinical trial conducted by the Howard-Hopkins Center to Reduce Asthma Disparities. The primary aim of that study was to test the clinical utility of the Asthma Control and Communication Instrument (ACCI), an asthma health status questionnaire specifically designed to be culturally appropriate for ethnically diverse populations. 23 
Study population
Adults (17 years of age) from 5 community-based outpatient primary care practices in Baltimore, Md, and Washington, DC, were enrolled if they (1) had doctor-diagnosed asthma, (2) were presenting for an already scheduled appointment, and (3) had evidence of active asthma based on recent symptoms and/or reliever medication use. Participants were excluded if they (1) were unable to speak and read English, (2) had previous participation in the study, or (3) had comorbidities that would interfere with the study. Primary care clinics were selected based on demographic data indicating that they served populations with a high proportion of African Americans. Subjects provided informed consent and received a small financial incentive of $30.00 for participation. Participants were not aware that the association between obesity and asthma control was being assessed. This study was approved by the Western Institutional Review Board (Spokane, Wash).
After enrollment, participants completed a comprehensive survey regarding demographics, general health information, and asthma history (ie, medications and health care use). Medications were classified as relievers (short-acting b-agonists) or long-term controllers, with the latter composed of inhaled corticosteroids, long-acting b-agonists, leukotriene modifiers, xanthines, IgE blockers, and mast cell stabilizers.
Asthma control
We assessed asthma control by using 4 different survey tools: the ACCI, the Asthma Control Test (ACT), the Asthma Control Questionnaire (ACQ), and the Asthma Therapy Assessment Questionnaire (ATAQ).
The ACCI is a 12-item self-administered survey that contains questions structured around 5 conceptual domains of asthma: acute care, bother from asthma, control, direction of disease activity, and adherence to long-term control medications. The control domain measures frequency of daytime symptoms, nocturnal symptoms, rescue medication use, asthma attacks, and activity limitation because of asthma. The ACCI has been found to have face and content validity. 23 Asthma control was defined as a sum score of the 5 control items which could range from 0 (better control) to 19 (worse control). 24 The ACT is a validated patient-completed questionnaire consisting of 5 items aimed at assessing asthma symptoms (daytime and nocturnal), use of rescue medications, and the effect of asthma on daily functioning. Each item includes 5 response options. The score ranges from 5 (poor control of asthma) to 25 (complete control of asthma). An ACT score of 19 or less provides optimum balance of sensitivity and specificity for detecting uncontrolled asthma. 25 The ACQ is a validated 7-item questionnaire that asks patients to recall their experiences during the previous week and respond to each question on a 7-point scale, which ranges from 0 (well controlled) to 6 (extremely poorly controlled). 18 Values are displayed as mean score ranging from 0 to 6. A score above 1.5 indicates poorly controlled asthma. We used the shortened version of the ACQ, which excludes pulmonary function parameters in the calculation of the overall score, because of possible effects of obesity on lung function. Previous studies have shown that exclusion of the pulmonary function parameters has no influence on the validity of the ACQ. 26 Last, the ATAQ, a self-administered 4-item questionnaire, was used to generate a 5-level measure of asthma control (0 5 no control problems to 4 5 4 control problems). 27 The scoring system reflects the level of asthma control in the past 4 weeks and identifies problems in disease management. 19, 20 A score greater than 0 indicates suboptimal controlled asthma.
Spirometry
Subjects underwent spirometric testing performed by trained personnel. All sites used the same model spirometer (KoKo Spirometer; Pulmonary Data Services, Lewisville, Colo). Spirometer calibration was checked using a 3-L syringe each day of testing. Spirometry techniques were carried out according to American Thoracic Society recommendations. 27 Maneuvers were done without the administration of albuterol. Percentage of predicted FEV 1 was calculated according to the reference values of Hankinson et al 28 adjusted for race/ethnicity.
BMI
Because of missing data, weight and height were based on self-report. Of 292 subjects, 199 and 45 had measured weight and height documented, respectively. Self-reported height and weight was validated by using measured height and weight obtained from medical charts. The Pearson coefficients for height (n 5 45), weight (n 5 199), and BMI (n 5 45) were 0.97, 0.97, and 0.94, respectively (all P < .01), with a mean difference of 1.06 kg between measured and self-reported weights. This observation is consistent with previous findings that show self-reported height and weight to be highly correlated with directly measured values. 29, 30 As such, self-reported height and weight were used in the final analysis to optimize our analytical power.
Body mass index was defined as the weight in kilograms divided by the square of height in meters. The international standard definition of obesity, as determined by the National Heart, Lung, and Blood Institute, was used. 31 
Statistical analysis
Subjects with BMI less than 18.5 kg/m 2 were excluded, because very low BMI can be associated with cachexia and advanced chronic illnesses. The association between BMI and asthma control was assessed using the Pearson correlation. The Pearson x 2 and ANOVA were used to assess the effects of obesity on categorical and continuous variables, respectively. By using the available sample size of 292 subjects, we have 80% power to detect a mean between-group difference of 0.26 with the ACQ based on a 2-sided a = 0.05. Univariate analysis was done to evaluate the association between (1) obesity and asthma control, and (2) increasing BMI level and asthma control. Multivariate regression models were used to adjust for potential confounders, such as age, race, sex, education, insurance, and smoking status (model 1). Another model (model 2) was used to adjust for additional confounders, which were hypothesized possibly to affect asthma control, including FEV 1 , forced vital capacity (FVC), and selected comorbidities: gastroesophageal reflux disease (GERD), rhinitis, chronic bronchitis, and sinusitis and use of asthma controllers. A 2-sided P value of less than .05 was used to determine statistical significance for all analyses. Computations were performed using STATA version 9.2 (College Station, Tex).
RESULTS

Patient characteristics
Of the 298 subjects who agreed to participate in the study, 6 participants were excluded from the analysis on the basis of missing BMI information (N 5 3) and BMI <18.5 kg/m 2 , leaving 292 subjects for the final analysis. The majority of the participants were black (63%) and women (82%) with a mean age of 47 years (SD, 15). Almost one third of the cohort reported having a less than a high school education (27%), and half had public health insurance (52%). There was a high prevalence of smoking, with almost two thirds of participants (63%) having a positive smoking history (36%, current smoker; 27%, former smoker). ). Analysis by BMI categories showed those who were obese to be more likely to be nonsmokers, have private insurance, and have higher level of education (P < .05). Although the gradient of FEV 1 /FVC ratio was not statistically different across BMI categories, increasing BMI level was associated with a lower median FEV 1 % predicted (P 5 .04), and FVC% predicted (P < .01).
Effect of obesity on asthma control
Mean scores from all 4 asthma control questionnaires, ACCI (8.3), ACT (15.4), ACQ (2.1), and ATAQ (1.3), demonstrated suboptimal asthma control on average, with 96% of the cohort meeting criteria for suboptimal control on at least 1 of the questionnaires. There was no association between BMI and asthma control using any of the 4 control questionnaires (P > .05). This finding persisted when the analysis was repeated using BMI as a categorical variable (Fig 1), or 
.03 Less than high school 78 (27) 17 (39) 16 (25) 12 (19) 13 (26) and mean level of asthma control using all 4 control instruments (Table III) .
Acute health care use and prescribed asthma medications
A substantial percentage of participants reported a history of hospitalization (13%) or emergency department visits (35%) for asthma-related complaints in the year preceding enrollment. The majority of subjects were actively being treated for asthma with a reliever (98%) or a long-term controller medication (63%). There was no difference in asthma-related acute health care use or prescribed asthma medication by BMI categories. There was a trend for obese subjects to be more likely to report using a longterm controller medication compared with those who were normal weight (67% vs 57%; P 5 .09).
DISCUSSION
In the current study, conducted in an urban population cared for in a primary care setting, obesity was not associated with worse asthma control. Obese patients had asthma control that was similar to that of the nonobese, and even among those who were obese, there was no tendency toward worse control with greater degrees of obesity. Although there are many health benefits associated with weight loss, findings from the current study do not suggest that weight loss would result in improved asthma control.
Our results add to published medical literature, in which there is evidence both for and against a link between obesity and asthma morbidity. Reports of the effects of obesity on asthma severity have been inconsistent, with some showing a positive association, [15] [16] [17] whereas others do not. 30, 32, 33 Recent studies that examined the effects of obesity on asthma control have been more consistently positive. 17, 30 However, differentiation between asthma control and asthma severity may be important when examining the effects of obesity. Even though asthma control and asthma severity are often used interchangeably, they are 2 distinct concepts, and thus may be affected differently by obesity. According to the latest asthma guidelines, asthma severity pertains to ''the intrinsic intensity of the disease process'' and should be used to initiate treatment, whereas asthma control refers to the ''degree to which the clinical manifestations are minimized and the goals of therapy are met'' and should be used to adjust therapy. 21 As such, obesity-related factors such as reduction in FVC and tidal volume, along with increased risk of gastrointestinal symptoms in the obese, may contribute to worse asthma control by increasing symptom reporting or seeming to decrease response to therapy without any effects on the intrinsic disease process. This concept is supported by a lack of objective evidence linking obesity to worse asthma pathophysiology, including airflow obstruction or airway inflammation. 11, [34] [35] [36] The distinction between assessment of severity and control is most striking in the study by Lavoie et al, 31 which found obesity to be associated with worse asthma control and not asthma severity, when the latter was assessed according to the 2002 Global Initiative for Asthma guidelines. Using a validated control instrument (the ACQ), obesity was found to be independently associated with worse asthma control. 30 In addition, suboptimal asthma control has been associated with several risk factors including demographics (ie, black, low socioeconomic status), 37 psychosocial factors (ie, depression, medication adherence), 38, 39 and environment (urban vs rural setting). 40 The contribution of these individual factors to asthma control and how they are affected by obesity is unknown. It is therefore unclear whether the high prevalence of some of these risk factors in our cohort, compared with previous studies showing a positive association between obesity and asthma control, accounts for our contradictory results by masking any effects of obesity on asthma control.
It is also important to consider that obesity and asthma are 2 highly prevalent clinical conditions that likely share environmental, behavioral, and genetic antecedents. For example, a diet high in calories (including certain fats and carbohydrates) may contribute to obesity, whereas the same diet may be lacking in foods (whole unprocessed fruits and vegetables, for example) with certain antioxidants, which could predispose to worse inflammation and oxidative stress. Sedentary lifestyles may contribute to obesity, but people with less active lifestyles may also spend a greater proportion of time in environments with factors that worsen asthma (eg, in a home with high allergen concentrations). Thus, previous studies that have found an association of obesity with asthma morbidity may have simply found the coincidence of illness severity that emanates from common underlying risk factors. Although the current study does not assess for these potential confounders, our findings highlight the potential complexity of the obesity and asthma relationship as well as underscore the need for studies that can adequately account for the distribution of suspected risk factors for both conditions. Our findings are strengthened by the use of 4 different asthma control measures, which assures that the absence of associations is unlikely to be attributable to misclassification of asthma control by a single survey. There was general agreement between the questionnaires regarding the degree of asthma control for the overall group. In addition, the use of the ACCI, an asthma control questionnaire specifically designed to be culturally sensitive, makes it unlikely that our findings are a result of potential limitations of the other questionnaires to assess level of asthma control adequately in this ethnically diverse population. 41 However, certain limitations of the current study design should be taken into account when interpreting our findings. Our findings may not generalize beyond our chosen study population. The current study population is representative of an outpatient urban primary care practice population well represented with African American and women patients, 2 groups with high asthma-related morbidity and obesity prevalence. 7 Because we selected patients who were seeking care in a clinical setting, our findings may not reflect patients at the well controlled end of the spectrum of control. If nonobese patients were less likely to attend the clinics, we may have underrepresented the impact of nonobese patients. Nevertheless, the range of BMI observed in our study included normal-weight people and a remarkable distribution of obesity, making it unlikely that a spectrum bias played an important role in our findings. In addition, although it is possible that our findings are reflective of unmeasured confounders, we tried to account for common comorbid conditions that may be associated with both obesity status and worst asthma control, such as active Acute care, N (%) Hospitalized within the past year 39 (13) 5 (11) 10 (15) 5 (8) 7 (14) 12 (17) .61 Emergency department visit within the past year 102 (35) 16 (36) 28 (43) 18 (29) 21 (42) 19 (27 smoking, GERD (51%), rhinitis (40%), sinusitis (54%), and chronic bronchitis (33%). However, even after consideration of these factors, we failed to detect any effects of BMI on asthma control in our regression analysis.
In conclusion, in our study of adults with asthma in an urban primary care setting, we did not find an association between obesity and asthma control, putting in question previous reports of a link between obesity and asthma control. The most recent National Asthma Education and Prevention Program guidelines recommend that obese patients with asthma ''may be advised that weight loss, in addition to improving overall health, might also improve asthma control.'' 21 This statement, although cautious, may be premature. At this point, evidence is needed from future clinical trials aimed at evaluating the effects of weight loss on asthma control. Until such trials are conducted, weight loss should of course be recommended for people with obesity for other health reasons, rather than for the sake of asthma control. Clinicians should continue to focus their attention on proven treatments including avoidance of environmental triggers and proper use of medications.
Clinical implications: Although weight loss has health benefits for those obese, it might not improve asthma control. Studies are needed to understand the effect of obesity on asthma control in different populations.
